For decades, keratoconus was described as a purely mechanical, non-inflammatory thinning of the cornea. That story is changing. A growing body of research points to enzymatic activity, oxidative stress, and inflammatory mediators in the tears of people with keratoconus, alongside the mechanical instability that corneal cross-linking is designed to halt.

In this episode, host Maya Rao sits down with Dr. Saikumar Gandapodi, Board-Certified Doctor of Oriental Medicine, Ayurvedic practitioner, and Founder of Netra Eye Institute, to explore what the evidence actually supports about the biology of keratoconus. They discuss the enduring value of cross-linking, the role of eye rubbing and the ocular surface, and where integrative, adjunct strategies might complement standard care.

Throughout, the conversation stays grounded: established science is separated from emerging hypotheses, no cures are promised, and integrative approaches are framed only as complements to proven ophthalmic treatment.

Normal-tension glaucoma challenges the old idea that glaucoma is simply a disease of high eye pressure. In this episode, Dr. Saikumar Gandapodi joins us to unpack what the evidence actually shows about optic nerve damage occurring at statistically normal intraocular pressures, and why blood flow, vascular regulation, and systemic factors matter so much here.

We explore Flammer syndrome, a described pattern of vascular dysregulation that shows up in some patients with normal-tension glaucoma, and separate what is established from what is still emerging. Dr. Gandapodi explains how conventional pressure-lowering care remains the proven foundation, and where careful, evidence-informed integrative support may complement it.

This is a research-driven conversation for an educated audience curious about the future of eye care. No cures are promised. Instead, we look honestly at the science of neuroprotection, ocular perfusion, and whole-person care around a condition that still keeps clinicians humble.

Glaucoma has long been defined by intraocular pressure — but a growing body of research shows that many patients continue to lose vision even when their pressure is beautifully controlled. Why? In this episode, host Priya Menon sits down with Dr. Saikumar Gandapodi, Board-Certified Doctor of Oriental Medicine, practitioner of Ayurvedic Medicine, and Founder and Director of Netra Eye Institute, to explore one of the most compelling frontiers in modern eye care: ocular blood flow and vascular dysregulation.

Together they unpack the science of optic nerve perfusion, endothelial dysfunction, Flammer Syndrome, oxidative stress, mitochondrial fragility, and the neurotrophic decline that leaves retinal ganglion cells vulnerable. Dr. Gandapodi translates concepts from vascular biology, functional medicine, and network pharmacology into an accessible framework — explaining where conventional, pressure-focused management is powerful, where it can fall short, and where adjunct, systems-based strategies may add value.

This is not a conversation about replacing surgery or medication. It is an evidence-informed exploration of the broader biological environment surrounding the optic nerve — from the gut-eye axis to Ginkgo biloba trials — and how Netra Restoration Therapy approaches glaucoma as a multifactorial, whole-person condition. Balanced, rigorous, and forward-looking, this episode is essential listening for patients and clinicians alike.